LRCX
Lam Research Corporation
—
389.04 $
+14.8600 (%+3.97)
Previous Close: 374.18
Day Low₺387.04001
Day High₺401
LRCX: Lam Research Corporation Financials
LRCX Income Statement
Total revenue
Net income
Gross margin TTM
48.71%
Operating margin TTM
32.01%
Net profit margin TTM
29.06%
Return on investment TTM
—
| Period end | 29/06/2025 | 30/06/2024 | 25/06/2023 | 26/06/2022 |
|---|---|---|---|---|
| Total revenue | 18,435,591,000 | 14,905,386,000 | 17,426,706,000 | 17,227,039,000 |
| Operating income | 5,900,968,000 | 4,263,913,000 | 5,174,860,000 | 5,381,822,000 |
| Net income | 5,358,217,000 | 3,827,772,000 | 4,510,931,000 | 4,605,286,000 |
All line items
| Line item | 29/06/2025 | 30/06/2024 | 25/06/2023 | 26/06/2022 |
|---|---|---|---|---|
| Total revenue | 18,435,591,000 | 14,905,386,000 | 17,426,706,000 | 17,227,039,000 |
| Cost of revenue | 9,456,532,000 | 7,852,595,000 | 9,651,591,000 | 9,355,232,000 |
| Gross profit | 8,979,059,000 | 7,052,791,000 | 7,776,925,000 | 7,871,807,000 |
| Research and development expenses | 2,096,387,000 | 1,902,444,000 | 1,727,162,000 | 1,604,248,000 |
| General and administrative expenses | 0 | 0 | 0 | 0 |
| Selling and marketing expenses | 0 | 0 | 0 | 0 |
| Selling, general and administrative expenses | 981,704,000 | 868,247,000 | 832,753,000 | 885,737,000 |
| Other expenses | 0 | 18,187,000 | 42,150,000 | 0 |
| Operating expenses | 3,078,091,000 | 2,788,878,000 | 2,602,065,000 | 2,489,985,000 |
| Cost and expenses | 12,534,623,000 | 10,641,473,000 | 12,253,656,000 | 11,845,217,000 |
| Net interest income | 53,128,000 | 66,702,000 | -47,478,000 | -169,550,000 |
| Interest income | 231,331,000 | 251,938,000 | 138,984,000 | 15,209,000 |
| Interest expense | 178,203,000 | 185,236,000 | 186,462,000 | 184,759,000 |
| Depreciation and amortization | 386,277,000 | 359,699,000 | 342,432,000 | 333,739,000 |
| EBITDA | 6,344,406,000 | 4,905,157,000 | 5,638,104,000 | 5,711,612,000 |
| EBIT | 5,958,129,000 | 4,545,458,000 | 5,295,672,000 | 5,377,873,000 |
| Non-operating income (excl. interest) | -57,161,000 | -281,545,000 | -120,812,000 | 3,949,000 |
| Operating income | 5,900,968,000 | 4,263,913,000 | 5,174,860,000 | 5,381,822,000 |
| Total other income/expenses (net) | 57,161,000 | 96,309,000 | -65,650,000 | -188,708,000 |
| Income before tax | 5,958,129,000 | 4,360,222,000 | 5,109,210,000 | 5,193,114,000 |
| Income tax expense | 599,912,000 | 532,450,000 | 598,279,000 | 587,828,000 |
| Net income from continuing operations | 5,358,217,000 | 3,827,772,000 | 4,510,931,000 | 4,605,286,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 5,358,217,000 | 3,827,772,000 | 4,510,931,000 | 4,605,286,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | 5,358,217,000 | 3,827,772,000 | 4,510,931,000 | 4,605,286,000 |
| EPS | 4 | 3 | 3 | 3 |
| Diluted EPS | 4 | 3 | 3 | 3 |
| Weighted average shares outstanding | 1,286,101,000 | 1,314,100,000 | 1,354,720,000 | 1,398,990,000 |
| Weighted average diluted shares outstanding | 1,290,142,000 | 1,319,950,000 | 1,358,340,000 | 1,406,280,000 |